Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
Title:
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
Author:
Haouala, A. Zanolari, B. Rochat, B. Montemurro, M. Zaman, K. Duchosal, M.A. Ris, H.B. Leyvraz, S. Widmer, N. Decosterd, L.A.
Appeared in:
Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences